Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position
Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activit...
Saved in:
Published in | International journal of molecular sciences Vol. 21; no. 16; p. 5829 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
13.08.2020
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens,
,
,
,
, and
. Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C
), overlapping with the optimum for antimicrobial activity (i.e., C
-C
). The most promising candidate (C
)
showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C
)
was further investigated in a time-kill experiment. |
---|---|
AbstractList | Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens,
,
,
,
, and
. Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C
), overlapping with the optimum for antimicrobial activity (i.e., C
-C
). The most promising candidate (C
)
showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C
)
was further investigated in a time-kill experiment. Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli. Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C10), overlapping with the optimum for antimicrobial activity (i.e., C8–C12). The most promising candidate (C8)5 showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C8)5 was further investigated in a time-kill experiment. Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Escherichia coli . Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C 10 ), overlapping with the optimum for antimicrobial activity (i.e., C 8 –C 12 ). The most promising candidate (C 8 ) 5 showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C 8 ) 5 was further investigated in a time-kill experiment. |
Author | Jensen, Signe Kaustrup Hansen, Paul R Thomsen, Thomas T Oddo, Alberto Franzyk, Henrik Løbner-Olesen, Anders |
AuthorAffiliation | 2 Department of Clinical Microbiology, Rigshospitalet, Henrik HarpestrengsVej 4A, 2100 Copenhagen, Denmark; thomas.thomsen@bio.ku.dk 3 Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark; lobner@bio.ku.dk 1 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; signekaustrupjensen@outlook.com (S.K.J.); albi.oddo@gmail.com (A.O.); henrik.franzyk@sund.ku.dk (H.F.) |
AuthorAffiliation_xml | – name: 1 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; signekaustrupjensen@outlook.com (S.K.J.); albi.oddo@gmail.com (A.O.); henrik.franzyk@sund.ku.dk (H.F.) – name: 3 Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark; lobner@bio.ku.dk – name: 2 Department of Clinical Microbiology, Rigshospitalet, Henrik HarpestrengsVej 4A, 2100 Copenhagen, Denmark; thomas.thomsen@bio.ku.dk |
Author_xml | – sequence: 1 givenname: Signe Kaustrup surname: Jensen fullname: Jensen, Signe Kaustrup organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark – sequence: 2 givenname: Thomas T orcidid: 0000-0003-3130-2784 surname: Thomsen fullname: Thomsen, Thomas T organization: Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark – sequence: 3 givenname: Alberto orcidid: 0000-0002-5759-9988 surname: Oddo fullname: Oddo, Alberto organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark – sequence: 4 givenname: Henrik orcidid: 0000-0002-2822-1927 surname: Franzyk fullname: Franzyk, Henrik organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark – sequence: 5 givenname: Anders orcidid: 0000-0002-0344-6417 surname: Løbner-Olesen fullname: Løbner-Olesen, Anders organization: Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark – sequence: 6 givenname: Paul R orcidid: 0000-0001-9357-8001 surname: Hansen fullname: Hansen, Paul R organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32823798$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUtvUzEQhS1URB-wY40ssSVgj-_1gwVSFBWoFFEWsLYcPxJHN_bFdirl33NDSpWuZjRz9M0ZnWt0kXLyCL2l5CNjinyK210FSnkvQb1AV7QDmBHCxcVZf4mua90SAgx69QpdMpDAhJJX6P5HfvADXhzsEC1exjGPfmzReTxPLa5ibtHWz_g2BG9bxTnguT1M-o2JCS99WrcNNsnhn7nGFnN6jV4GM1T_5rHeoN9fb38tvs-W99_uFvPlzHZCthnzLHjnDBFCKcm7HjidjErJwHPDVsqAtQFob5RzDIjx3kmQHBzhwUjObtDdieuy2eqxxJ0pB51N1P8Guay1KZP3wWvJLfOUA7Oy70iwCqgIgvWccOs6dWR9ObHG_WrnnfWpFTM8gz7fpLjR6_ygRcdpz-UEeP8IKPnP3temt3lf0vS_ho71hFAujmc-nFS25FqLD08XKNHHKPV5lJP83bmrJ_H_7Nhfkw2axA |
CitedBy_id | crossref_primary_10_1002_psc_3560 crossref_primary_10_1016_j_ejmcr_2022_100080 crossref_primary_10_3390_ijms21249552 crossref_primary_10_1016_j_foodchem_2024_139119 crossref_primary_10_3390_ijms241914801 crossref_primary_10_1039_D1TB02852A crossref_primary_10_3390_ijms24065505 crossref_primary_10_3390_ph16030439 crossref_primary_10_1016_j_biotechadv_2023_108210 crossref_primary_10_1016_j_ijbiomac_2023_124884 crossref_primary_10_4155_fmc_2022_0160 crossref_primary_10_1016_j_ejmech_2024_116337 crossref_primary_10_1016_j_molstruc_2022_133382 crossref_primary_10_1021_acs_bioconjchem_2c00519 crossref_primary_10_3390_antibiotics11081080 |
Cites_doi | 10.1038/ja.2013.111 10.1016/S0005-2736(99)00198-4 10.1016/j.cbpa.2017.02.006 10.1371/journal.pone.0071151 10.1080/00304948.2016.1127096 10.3390/antibiotics9010024 10.3389/fmicb.2019.00539 10.3390/antibiotics9070366 10.1002/(SICI)1097-0282(1997)43:1<15::AID-BIP3>3.0.CO;2-3 10.1021/cb4006613 10.1016/j.jcis.2009.11.057 10.1128/AAC.00925-06 10.1038/415389a 10.1007/978-1-4939-6737-7 10.1038/s41579-019-0288-0 10.3389/fmicb.2019.01689 10.1007/978-1-4939-6737-7_31 10.1016/j.mib.2017.10.028 10.1038/s41573-019-0058-8 10.1046/j.1432-1033.2001.02494.x 10.1128/AAC.01966-15 10.1038/nprot.2007.521 10.1086/429323 10.3390/molecules22091430 10.3109/07388551.2011.594423 10.1016/S0014-5793(01)02648-5 10.3390/molecules24183314 10.1021/cb500080r 10.1110/ps.072966007 10.1128/AAC.02340-16 10.1021/bi00892a002 |
ContentType | Journal Article |
Copyright | 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 by the authors. 2020 |
Copyright_xml | – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 by the authors. 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 5PM DOA |
DOI | 10.3390/ijms21165829 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest research library Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496 10_3390_ijms21165829 32823798 |
Genre | Journal Article |
GroupedDBID | --- 29J 2WC 3V. 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ ABDBF ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV AEAQA AENEX AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 DWQXO E3Z EBD EBS ECM EIF EJD ESTFP ESX F5P FRP FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HH5 HMCUK HYE IAO KB. KQ8 LK8 M1P M2O M48 M7P MODMG M~E NPM O5R O5S OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M AAHBH AAYXX ALIPV CITATION 7XB 8FK ITC K9. MBDVC PQEST PQUKI PRINS Q9U 5PM |
ID | FETCH-LOGICAL-c478t-3e3fedda0779986452610068832e6a3b9a2ccf215a9dd320aeed82862d06fa863 |
IEDL.DBID | RPM |
ISSN | 1422-0067 1661-6596 |
IngestDate | Fri Jul 05 11:49:44 EDT 2024 Tue Sep 17 21:27:49 EDT 2024 Tue Sep 24 21:20:43 EDT 2024 Fri Aug 23 04:57:51 EDT 2024 Thu May 23 23:41:02 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Keywords | fatty acid hydrophobicity cyclic lipopeptides antimicrobial peptides colistin |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-3e3fedda0779986452610068832e6a3b9a2ccf215a9dd320aeed82862d06fa863 |
Notes | Current address: Novo Nordisk A/S, Krogshøjvej 44, 2820 Bagsværd, Denmark. |
ORCID | 0000-0002-5759-9988 0000-0002-0344-6417 0000-0002-2822-1927 0000-0001-9357-8001 0000-0003-3130-2784 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461568/ |
PMID | 32823798 |
PQID | 2435001676 |
PQPubID | 2032341 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7461568 proquest_journals_2435001676 crossref_primary_10_3390_ijms21165829 pubmed_primary_32823798 |
PublicationCentury | 2000 |
PublicationDate | 20200813 |
PublicationDateYYYYMMDD | 2020-08-13 |
PublicationDate_xml | – month: 8 year: 2020 text: 20200813 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2020 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Howard (ref_21) 2016; 48 Falagas (ref_16) 2005; 40 ref_14 ref_13 ref_11 ref_32 Oddo (ref_33) 2016; 60 Zorzi (ref_15) 2017; 38 Epand (ref_30) 1997; 43 Nielsen (ref_22) 2007; 16 Theuretzbacher (ref_4) 2020; 18 ref_18 ref_17 Vaara (ref_19) 2019; 10 Deris (ref_12) 2014; 67 Cleland (ref_23) 1964; 3 Chen (ref_28) 2007; 51 Epand (ref_10) 1999; 1462 Velkov (ref_20) 2014; 9 Zasloff (ref_6) 2002; 415 Li (ref_25) 2014; 9 Dathe (ref_27) 2001; 501 Wiegand (ref_24) 2008; 3 Oddo (ref_31) 2017; 1548 Nguyen (ref_29) 2010; 345 Mulani (ref_2) 2019; 10 Theuretzbacher (ref_1) 2017; 39 ref_3 Pasupuleti (ref_9) 2012; 32 Giangaspero (ref_26) 2001; 268 ref_8 ref_5 Mookherjee (ref_7) 2020; 19 |
References_xml | – volume: 67 start-page: 147 year: 2014 ident: ref_12 article-title: A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity publication-title: J. Antibiot. (Tokyo) doi: 10.1038/ja.2013.111 contributor: fullname: Deris – volume: 1462 start-page: 11 year: 1999 ident: ref_10 article-title: Diversity of antimicrobial peptides and their mechanisms of action publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(99)00198-4 contributor: fullname: Epand – volume: 38 start-page: 24 year: 2017 ident: ref_15 article-title: Cyclic peptide therapeutics: Past, present and future publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2017.02.006 contributor: fullname: Zorzi – ident: ref_17 doi: 10.1371/journal.pone.0071151 – volume: 48 start-page: 1 year: 2016 ident: ref_21 article-title: Preparation and Applications of 4-Methoxybenzyl Esters in Organic Synthesis publication-title: Org. Prep. Proced. Int. doi: 10.1080/00304948.2016.1127096 contributor: fullname: Howard – ident: ref_32 – ident: ref_3 – ident: ref_13 doi: 10.3390/antibiotics9010024 – volume: 10 start-page: 539 year: 2019 ident: ref_2 article-title: Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.00539 contributor: fullname: Mulani – ident: ref_18 doi: 10.3390/antibiotics9070366 – volume: 43 start-page: 15 year: 1997 ident: ref_30 article-title: Biophysical studies of lipopeptide-membrane interactions publication-title: Biopolymers doi: 10.1002/(SICI)1097-0282(1997)43:1<15::AID-BIP3>3.0.CO;2-3 contributor: fullname: Epand – volume: 9 start-page: 211 year: 2014 ident: ref_25 article-title: Lipidated Cyclic gamma-AApeptides Display Both Antimicrobial and Anti-inflammatory Activity publication-title: ACS Chem. Biol. doi: 10.1021/cb4006613 contributor: fullname: Li – volume: 345 start-page: 160 year: 2010 ident: ref_29 article-title: Chain length dependence of antimicrobial peptide–fatty acid conjugate activity publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2009.11.057 contributor: fullname: Nguyen – volume: 51 start-page: 1398 year: 2007 ident: ref_28 article-title: Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00925-06 contributor: fullname: Chen – volume: 415 start-page: 389 year: 2002 ident: ref_6 article-title: Antimicrobial peptides of multicellular organisms publication-title: Nature doi: 10.1038/415389a contributor: fullname: Zasloff – ident: ref_8 doi: 10.1007/978-1-4939-6737-7 – volume: 18 start-page: 275 year: 2020 ident: ref_4 article-title: The global preclinical antibacterial pipeline publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-019-0288-0 contributor: fullname: Theuretzbacher – volume: 10 start-page: 1689 year: 2019 ident: ref_19 article-title: Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics publication-title: Front. Microbiol. doi: 10.3389/fmicb.2019.01689 contributor: fullname: Vaara – volume: 1548 start-page: 427 year: 2017 ident: ref_31 article-title: Hemolytic Activity of Antimicrobial Peptides publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-6737-7_31 contributor: fullname: Oddo – volume: 39 start-page: 106 year: 2017 ident: ref_1 article-title: Global antimicrobial resistance in Gram-negative pathogens and clinical need publication-title: Curr. Opin. Microbiol. doi: 10.1016/j.mib.2017.10.028 contributor: fullname: Theuretzbacher – volume: 19 start-page: 311 year: 2020 ident: ref_7 article-title: Antimicrobial host defence peptides: Functions and clinical potential publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-019-0058-8 contributor: fullname: Mookherjee – volume: 268 start-page: 5589 year: 2001 ident: ref_26 article-title: Amphipathic α helical antimicrobial peptides publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1033.2001.02494.x contributor: fullname: Giangaspero – volume: 60 start-page: 592 year: 2016 ident: ref_33 article-title: An all-D amphipathic undecapeptide shows promising activity against colistin-resistant strains of Acinetobacter baumannii and a dual mode of action publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01966-15 contributor: fullname: Oddo – volume: 3 start-page: 163 year: 2008 ident: ref_24 article-title: Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances publication-title: Nat. Protoc. doi: 10.1038/nprot.2007.521 contributor: fullname: Wiegand – volume: 40 start-page: 1333 year: 2005 ident: ref_16 article-title: Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections publication-title: Clin. Infect. Dis. doi: 10.1086/429323 contributor: fullname: Falagas – ident: ref_14 doi: 10.3390/molecules22091430 – volume: 32 start-page: 143 year: 2012 ident: ref_9 article-title: Antimicrobial peptides: Key components of the innate immune system publication-title: Crit. Rev. Biotechnol. doi: 10.3109/07388551.2011.594423 contributor: fullname: Pasupuleti – volume: 501 start-page: 146 year: 2001 ident: ref_27 article-title: Optimization of the antimicrobial activity of magainin peptides by modification of charge publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02648-5 contributor: fullname: Dathe – ident: ref_5 doi: 10.3390/molecules24183314 – volume: 9 start-page: 1172 year: 2014 ident: ref_20 article-title: Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’ publication-title: ACS Chem. Biol. doi: 10.1021/cb500080r contributor: fullname: Velkov – volume: 16 start-page: 1969 year: 2007 ident: ref_22 article-title: Structure activity study of the antibacterial peptide fallaxin publication-title: Protein Sci. doi: 10.1110/ps.072966007 contributor: fullname: Nielsen – ident: ref_11 doi: 10.1128/AAC.02340-16 – volume: 3 start-page: 480 year: 1964 ident: ref_23 article-title: Dithiothreitol, a New Protective Reagent for SH Groups publication-title: Biochemistry doi: 10.1021/bi00892a002 contributor: fullname: Cleland |
SSID | ssj0023259 |
Score | 2.4080548 |
Snippet | Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin,... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 5829 |
SubjectTerms | Acylation Anti-Bacterial Agents - chemical synthesis Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibiotics Antiinfectives and antibacterials Antimicrobial activity Antimicrobial agents antimicrobial peptides Bacteria Colistin cyclic lipopeptides Cyclization Erythrocytes fatty acid Fatty acids Fatty Acids - chemistry Gram-negative bacteria Gram-positive bacteria Hemolysis - drug effects Hydrophobic and Hydrophilic Interactions Hydrophobicity Klebsiella Lipopeptides Lipopeptides - chemical synthesis Lipopeptides - chemistry Lipopeptides - pharmacology Microbial Sensitivity Tests Molecular weight Multidrug resistance Pathogens Peptide synthesis Peptides Pseudomonas aeruginosa Pseudomonas aeruginosa - drug effects Solid phases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NSwMxEA0iCF7Eb6tVctDjYptsk423WiwiWj1Y8Lak-bArultsFfrvndlsayuCF6-bwA4zG96bzcwbQk6ZtExLwyIf4zUja8RRYrmL9ECD3RJAt5w8d9cT1_345qn1tDDqC2vCgjxwcNx5Igx3TQBpkwC58EYBh_aSA1ALY2MVxLabrVkyVaVanJVj0pqAPpFoKRFK3jkk-OfZy9uYoehMUtLKbzAqNft_I5o_6yUXAKi7STYq5kjbweItsuLybbIWZklOd8h9r_h0r7QzNa-ZobfZqBhhwYp1tJ1jX0iBeswXNKgVj2nhadtMYf9QZzm9dfnzZEh1bulDVcW1S_rdq8fOdVRNS4hMLJNJxB33zlrdkFKh5noLciNsAIEj64TmA6WZMR4QXitrOWtoQEfsIWe2IbxOBN8jq3mRuwNCrfR4G-c50yoeOBxGhj-ImPFaCOVNjZzN3JaOgihGCskEujdddG-NXKJP53tQyrp8AAFOqwCnfwW4RuqziKTV-RqnDFhe2UEBy_shOPO3cIYCPCqpEbkUtiUzllfybFgqa8sYCJ5IDv_D7iOyzjA3R_lcXierk_cPdwwEZjI4Kb_VL9Cc6q0 priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED8x0KS9TMC-Mj7kB_YYtbVTO94LKghUIejQNCTeIscfNBNLOppN6n-_uyQtdEK8JpZs3dm-3_nufgdwxJXjRlkeh4TCjLyfxKkTPja5wXUrNLpN57mriRzfJBe3w9sNGC9rYSitcnknNhe1qyy9kfc42vUmZ172TE6vALbuHc9-x9Q_iuKsXTONV7DFBwkFbLdOzibX31fOl-BN47QB2qNYDrVsk-AFuvy94uevOScamrQBmo_mqWHxfw56_p9B-cQknW_D2w5LslGr_B3Y8OUuvG67Sy7ewbdJ9dffs9OFvS8suyxm1YxSWJxno5IqRSpiaP7KWv7iOasCG9kFjp-aomSXvryrp8yUjl13eV3v4eb87MfpOO76J8Q2UWkdCy-Cd870ldLEwj5Eb4lKQvAQe2lErg23NqDNN9o5wfsG7SVVlXPXl8GkUnyAzbIq_SdgTgWKzwXBjU5yT-3J6MmI22Ck1MFG8GUptmzW0mRk6F6QeLOn4o3ghGS6GkPk1s2H6uEu685Klkor_ABxmU0RTwar0W0KSiA2k9YlWkawv9RI1p24efa4PyL42CpnNYvgRMmj0wjUmtrWlrH-pyymDde2ShDyyfTzy1PuwRtOfjhR5Yp92Kwf_vgDBCt1ftjtw39I6uiH priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4BVSUuCEofy0s-lGPoYnvtGKmqtgiEKl4HVuIWef1gUy0J7C6I_fedSbIrtuXYa-wozoyd-b7Y8w3AV649t9rxJEraZuRtmaRehMT2LY5bY9CtKs9dXKqznvx127ldglm10caA4zepHdWT6o2GBy-P0x-44L8T40TK_i3_fT_mJCOTcrMM77gUkub6hZzvJyBsqMqmHWI0SlTHqPoI_D93LwSnSsP_LeD59_nJVwHpdB3WGiTJurXrN2ApFB_gfV1bcroJV5flcxiy46kb5o6d5w_4Xvh58IF1C8oTKUmf-YjV6sVjVkbWdVPsP7B5wc5DcTcZMFt4dt2c6voIvdOTm-OzpKmekDip00kigojBe9vW2pAGewe5EiWE4BIOyoq-sdy5iBHfGu8Fb1uMlpRTzn1bRZsq8QlWirIIX4B5HWl3LgpujewHKk5GP4y4i1YpE10L9mdmyx5qkYwMyQWZN3tt3hb8JJvO-5C0dXWhHN1lzUrJUuVEOERU5lJEk9EZJE1RC0RmynlpVAt2Zh7JZtMlQ593qowKbP5cO2f-FMFJkMekLdALblsYxmJLkQ8qpW0tEfCpdOt_jHsbVjlxdZLTFTuwMhk9hV0ENJP-XjVX_wAt8_KN priority: 102 providerName: Scholars Portal |
Title | Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32823798 https://www.proquest.com/docview/2435001676/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC7461568 https://doaj.org/article/86c3e1623c8540fc9217f735606cd496 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISReEN8URuQHeMxa7NR2eOuqlQmtpUJM6lvk-GPN1DrVWpD633PnJNOKeOLFD7GjWHdn3f3iu98R8pFJy7Q0LPUZXjOyQZYqy12qSw37luB0Y-e56UxcXmffFsPFERl2tTAxad-U1VlYrc9CtYy5lZu16Xd5Yv35dCwz8MNC9Y_JseS8g-gtyuIQ0DcZ7hzwfL-6XW8ZcswohgyhnCE7S64O3FBk6_9XiPl3puQD1zN5Rp62MSMdNXt7To5ceEEeN10k9y_J91n9263oeG9WlaFX1abeYKqKdXQUsCKkRibmL7ThKd7S2tOR2cP6pa4CvXLhZrekOlg6b_O3XpHrycXP8WXa9klITSbVLuWOe2etHkiZI9v6EFARln7AYXVC8zLXzBgPvl3n1nI20OAXsXqc2YHwWgn-mpyEOri3hFrp8R7Oc6bzrHTYhgx_DTHjtRC5Nz3yqRNbsWnoMAqAESjp4qGke-QcZXq_Bkms44P67qZoVVkoYbj7DPGXURA3epMDPPKSQwwmjM1y0SOnnUaK9mRtCwbxXaydgOk3jXLuv9Ipt0fkgdoOtnE4AyYWObVbk3r332--J08YQnFky-Wn5GR398t9gHhlVyZgpQsJo5p8Tcij84vZ_EcSsX-CfmQI4zRTSbTiP2Iv8Lw |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,12083,12792,21416,24346,27957,27958,31754,33408,33779,43345,43635,43840,53827,53829,74102,74392,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NbxMxEB1BEYILKp9dKOADHFdNbcdec0FpRRUgDRxaKbeV449mUbsbmoCUf8-Md9M0CHHdtWRrxva8sZ_fALzj2nOrHc-jpGtG3pN54UXI7dTiuDUG3VR57nSshufyy6Q_6Q7cFh2tcr0npo3aN47OyA84xvXEmVcf5z9zqhpFt6tdCY27cE8KIYnSpyebhEvwVCztEGNQrvpGtcR3gWn-QfXjasFJeqZI4HITkpJy_7_g5t-syVth6GQXHnX4kQ1ahz-GO6F-AvfbipKrp_Bt3PwOl-x45S4rx0bVvJkTbcUHNqjpdUhDqswfWKtZvGBNZAO3wvYzW9VsFOqL5YzZ2rPvHZfrGZyffDo7HuZdzYTcSV0scxFEDN7bntaGlNf7mCHRMxBcuEFZMTWWOxcxzlvjveA9izGSXpJz31PRFko8h526qcMeMK8j3clFwa2R00AlyeiYiLtolTLRZfB-bbZy3kpjlJhSkHnL2-bN4IhsetOGBK3Th-b6ouzWR1koJ8IhYjFXIIaMzmCqFLVAPKacl0ZlsL_2SNmtskW5mRMZvGidc9OL4CTDY4oM9Jbbtoax_aeuZklfW0uEeap4-f8u38KD4dnpqBx9Hn99BQ855eEklSv2YWd5_Su8RrCynL5JM_IPKxTmVA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NbxMxEB1BEagXVD67UMAHOK6ytTf2mgtKC1GBEHqgUm4rxx_NonY3bQJS_j0z3k3TIMR115KtGdvzxn5-A_CWK8eNsjwNOV0z8ixPCyd8aqYGx60w6MbKc9_G8uQs_zLpTzr-06KjVa73xLhRu8bSGXmPY1yPnHnZCx0t4vTj8MP8KqUKUnTT2pXTuAv3MEpmVM1ATTbJl-CxcNohxqNU9rVsSfACU_5e9fNywUmGpohAcxOeoor_v6Dn3wzKWyFpuAcPOyzJBq3zH8EdXz-G-211ydUT-D5ufvsLdryyF5Vlo2rezInC4jwb1PRSpCGF5ves1S9esCawgV1h-5mpajby9flyxkzt2GnH63oKZ8NPP45P0q5-QmpzVSxT4UXwzplMKU0q7H3MluhJCC5iL42YasOtDRjzjXZO8MxgvKRX5dxlMphCimewUze13wfmVKD7uSC40fnUU3kyOjLiNhgpdbAJvFubrZy3Mhklphdk3vK2eRM4IpvetCFx6_ihuT4vu7VSFtIKf4i4zBaIJ4PVmDYFJRCbSetyLRM4WHuk7FbcotzMjwSet8656UVwkuTRRQJqy21bw9j-U1ezqLWtcoR8snjx_y7fwAOcjOXo8_jrS9jllJKTaq44gJ3l9S__CnHLcvo6Tsg_3sDqgA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Cyclic+Lipopeptide+Antibiotics%3A+Effects+of+Acyl+Chain+Length+and+Position&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Signe+Kaustrup+Jensen&rft.au=Thomas+T.+Thomsen&rft.au=Alberto+Oddo&rft.au=Henrik+Franzyk&rft.date=2020-08-13&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=21&rft.issue=16&rft.spage=5829&rft_id=info:doi/10.3390%2Fijms21165829&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |